Anika Therapeutics (ANIK) Free Cash Flow Growth (1y) (2011 - 2026)
Powered by 
Analysis
Anika Therapeutics (ANIK) Free Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 28.87% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 69.33% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 120.89% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 14.12% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 13.29% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 142.84% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -0.16% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | -11.68% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -14.34% |
| 10 | Anika Therapeutics | 277.93 Mn | 239.52 Mn | 21.24 Mn | -28.80% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -28.80% |
| Mar 31, 2026 | -112.49% |
| Dec 31, 2025 | 1,350.55% |
| Sep 30, 2025 | 31.13% |
| Jun 30, 2025 | 62.97% |
| Mar 31, 2025 | -52.74% |
| Dec 31, 2024 | -84.71% |
| Sep 30, 2024 | -33.84% |
| Jun 30, 2024 | 54.13% |
| Mar 31, 2024 | 61.37% |
| Dec 31, 2023 | 187.79% |
| Sep 30, 2023 | 464.24% |
| Jun 30, 2023 | -949.30% |
| Mar 31, 2023 | -56.71% |
| Dec 31, 2022 | -161.23% |
| Sep 30, 2022 | 30.85% |
| Jun 30, 2022 | -46.15% |
| Mar 31, 2022 | -6.46% |
| Dec 31, 2021 | 56.45% |
| Sep 30, 2021 | -86.09% |